Abstract
Objectives: Infantile colic is a condition which is seen commonly in infants that has psychosocial effects. The objective of this study was to evaluate the effectiveness of synbiotics with 4 bacterial strains - Streptococcus faecalis, Clostridium butyricum, Bacillus mesentricus and Lactobacillus sporogenes as an add on therapy to standard treatment for the management of infantile colic by measuring the reduction in mean daily crying time.
Materials and Methods: An observational, randomized, clinical study was done in Dept of Pediatrics, RMMCH, Annamalai University, Chidambaram involving fifty breastfed infants aged 30 - 180 days with abdominal colic. They were alloted into two groups- Group A and Group B by randomization. Infants in Group A were given standard treatment with Dimethicone for 5 days and infants in Group B were given standard treatment for 5 days and synbiotic for 28 days. Parents had been asked to record the crying times and the infants were followed up and the reduction in mean crying time (100 % reduction) was noted on day 7, 14 and 28.
Results: Infants assigned to synbiotic group showed rapid improvement in terms of reduction in mean daily crying time (100 % reduction – P 0.001) in comparison to standard treatment alone.
Conclusion: It was concluded from this study that it is safe, effective and beneficial to use synbiotic as an add on therapy to standard treatment to manage abdominal colic in infants.
Keywords: Infantile colic, synbiotic, Reduction in crying time.
References
- Savino F, Tarasco V: New treatments for infant colic. Current Opinion in Pediatrics 2010, 22:791–7.
- Anabrees, J., Indrio, F., Paes, B. & Alfaleh K. Probiotics for infantile colic: a system-atic review. BMC Pediatr. 2013, 13: 186.
- Valerie Sung, Harriet Hiscock, Mimi Tang, Fiona K Mensah, Ralf G Heine, Amanda Stock, Elissa York, Ronald G Barr and Melissa Wake Probiotics to improve outcomes of colic in the community: Protocol for theBaby Biotics randomised controlled trial, BMC Pediatrics;2012-12:135
- Sumitha Nayak, Infantile Colic –Do we understand the Etiology?, march 2011,vol 2;issue 1
- Eberi G,Lochner M. The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunol.2009,155:823-8
- Rhoads JM, Fatheree NY, Norori J, Liu Y, Lucke JF, Tyson JE, et al. Altered fecal microflora and increased fecal calprotectin in infants with colic.J Pediatr2009; 155:823-8.
- de Weerth C, Fuentes S, Puylaert P, et al. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 2013; 131: 550–558.
- Dan W. Thomas, MD, Frank R. Greer, MD, and the Committee on Nutrition and the Section on Gastroenterology, Hepatology, and Nutrition., Probiotics and Prebiotics in Pediatrics, 2010,126: 1217
- Ger T. Rijkers, Stig Bengmark, Paul Enck, Dirk Haller, Udo Herz, Marko Kalliomaki, Satoshi Kudo et al. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: J. Nutr.2010, 140: 671S–676S.
- Savino F,Pelle E, Palumeri E,Oggero R,Miniero R.Lactobacillus reuteri ATCC 55730 vs simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 2007; 119;e124-30
- Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 2010;126: 526–33.
- Szajewska, H., Gyrczuk, E. & Horvath, A. (2013) Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: A randomized, doubleblind, placebo-controlled trial. J. Pediatr., 162, 257-262.
- Kianifar H, Ahanchian H, Grover Z, et al. Synbiotic in the management of infantile colic: a randomised controlled trial. J Paediatr Child Health 2014; 50:801–5.
Corresponding Author
T.Vijayalakshmi
Post Graduate, Department of Paediatrics,
RMMCH, Chidambaram-608002, Tamilnadu, India
DOI: https://dx.doi.org/10.18535/jmscr/v5i11.139
